ATOSSA THERAPEUTICS, INC. Share-based Payment Arrangement, Amount Capitalized
ATOSSA THERAPEUTICS, INC. (ATOS) reported Share-based Payment Arrangement, Amount Capitalized of $840.10 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Notes › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2016-03-30
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2015-12-31 was $136.38K, a 1120.49% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2015-09-30 was $317.99K, a 115.73% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2015-06-30 was $205.11K, a 22.43% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2015-03-31 was $180.63K, a 21.53% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for fiscal 2015 was $840.10K, a 51.02% increase from fiscal 2014.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for fiscal 2014 was $556.29K, a 61.47% decline from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. share-based payment arrangement, amount capitalized for fiscal 2013 was $1.44M.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month | Share-based Payment Arrangement, Amount Capitalized 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $136.38K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $454.36K derived: sum of 2 quarters · filed 2016-03-30 | $659.48K derived: sum of 3 quarters · filed 2016-03-30 | $840.10K 10-K · filed 2016-03-30 | |
| 2015-09-30 | $317.99K 10-Q · filed 2015-11-12 | $523.10K derived: sum of 2 quarters · filed 2015-11-12 | $703.73K 10-Q · filed 2015-11-12 | $714.90K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-06-30 | $205.11K 10-Q · filed 2015-08-06 | $385.74K 10-Q · filed 2015-08-06 | $396.91K derived: sum of 3 quarters · filed 2016-03-30 | $544.31K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-03-31 | $180.63K 10-Q · filed 2015-05-13 | $191.80K derived: sum of 2 quarters · filed 2016-03-30 | $339.20K derived: sum of 3 quarters · filed 2016-03-30 | $506.74K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-12-31 | $11.17K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $158.57K derived: sum of 2 quarters · filed 2016-03-30 | $326.11K derived: sum of 3 quarters · filed 2016-03-30 | $556.29K 10-K · filed 2016-03-30 | $698.66K 10-K · filed 2015-03-30 |
| 2014-09-30 | $147.40K 10-Q · filed 2015-11-12 | $314.93K derived: sum of 2 quarters · filed 2015-11-12 | $545.11K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $167.53K 10-Q · filed 2015-08-06 | $397.71K 10-Q · filed 2015-08-06 | |||
| 2014-03-31 | $230.18K 10-Q · filed 2015-05-13 | ||||
| 2013-12-31 | $1.44M 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |